Skip to main content

Podcast: All Things Cardio-Oncology

Listen to the podcast of the International Cardio-Oncology Society here.

Certification Exam in Cardio-Oncology Knowledge

Apply for the IC-OS Certification Exam in Cardio-Oncology Knowledge here.

IC-OS Board Exam Review Book

Purchase the IC-OS Board Exam Review Book here.

Practical approaches to care

We're excited to announce a new Cardio-Oncology initiative: "Practical Approaches to Cardio-Oncology Care." We invite manuscripts dealing with state-of-the-art management of common clinical cardio-oncology issues and toxicities, e.g., “How to manage pericardial effusions.” As part of a new series, we will offer expedited reviews for rapid processing. See here for details.

Aims and scope

The editorial mission of Cardio-Oncology is to advance the science and practice of this emerging field to find a balance between oncologic efficacy and reducing adverse cardiovascular effects through timely publication and dissemination of peer-reviewed research. As an open access, online journal Cardio-Oncology provides a high visibility platform for the publication of original research and expert reviews on the cardiovascular effects of cancer treatment. Read more here.


Manuscript pre-screening

Manuscripts can be pre-screened by the Editor-in-Chief and Deputy Editors. Please email all manuscript files to the Publishing Editor prior to submitting via the submission site. Pre-screened papers will then be offered peer review after formal submission.

Apply to our Trusted Reviewer Board

Cardio-Oncology has launched a new Trusted Reviewer Board composed of early career researchers. To learn more, and to apply, please visit the application form.

By joining the board as a Trusted Reviewer, you will be part of our very first official Reviewer Board, gain editorial experience, and refine your reviewing skills. The role comes with a plethora of other benefits, including:

New Content Item (1)

Could your research help reduce toxicities from cancer therapy? Submit your funding proposal to HESI Thrive  by April 8, 2024, and help make cancer patient quality of life an active research priority!

Colorectal Cancer Awareness Month

In recognition of Colorectal Cancer Awareness Month this March, we have selected a collection of articles on colorectal cancer from across our open access portfolio. Together, these articles contribute to the evolving landscape of colorectal cancer research and the fight against this prevalent and impactful disease.
© Mopic /

Cross-journal collections

We are proud to announce that Cardio-Oncology is taking part in two new cross-journal collections "Cancer Disparities" and "Long-term Impact of COVID in Cancer Patients." Both collections are now open for submissions.

About the society

Cardio-Oncology is the official journal of the International Cardio-Oncology Society (ICOS). The society brings together cardio-oncologists from around the world with the aim of reducing cardiovascular disease in cancer patients and thereby saving patients' lives. For more information about this important work, please visit the ICOS website.

Peer Review Taxonomy

This journal is participating in a pilot of NISO/STM's Working Group on Peer Review Taxonomy, to identify and standardize definitions and terminology in peer review practices in order to make the peer review process for articles and journals more transparent. Further information on the pilot is available here.

The following summary describes the peer review process for this journal:

Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: None

We welcome your feedback on this Peer Review Taxonomy Pilot. Please can you take the time to complete this short survey.

Get to know our Section Editors

Thomas D. Ryan, MD, PhD

New Content Item

Thomas D. Ryan, MD, PhD, FAAP, FACC, FAHA is the Director of Clinical Operations in the Cardiomyopathy and Heart Failure Program, and the founding Co-Director of the Cardio-Oncology Program at Cincinnati Children’s Hospital Medical Center (CCHMC). He is also an Associate Professor of Pediatrics-Clinical at the University of Cincinnati College of Medicine.

Dr. Ryan graduated magna cum laude from Wichita State University with a BS in Biological Sciences and earned both an MD and PhD at the University of Alabama School of Medicine/University of Alabama at Birmingham. He completed general pediatrics residency and pediatric cardiology fellowship at CCHMC and was the first graduate of the CCHMC Heart Institute’s Advanced Fellowship in Pediatric Heart Failure, Cardiomyopathy, and Cardiac Transplantation.

Dr. Ryan’s clinical and research interests focus on inherited and acquired cardiomyopathy as well as cardiac transplantation. He has particular emphasis on patients who have developed heart dysfunction because of cancer-related therapies. He has published over 70 manuscripts in peer-reviewed journals and is author of 10 textbook chapters. He was on the founding Leadership Council for the Cardio-Oncology Member Section of the American College of Cardiology and was the first Chair of the Pediatric Working Group. Dr. Ryan serves as Co-Chair of the Institutional Review Board at CCHMC, as well as Section Editor for the journal Cardio-Oncology.

About the Editors

Steven Lipshultz, Editor-in-Chief

Steven E. Lipshultz, MD, FAAP, FAHA is the A. Conger Goodyear Professor and Chair of the Department of Pediatrics at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, The State University of New York; the Chief of Service of Pediatrics at Kaleida Health; the Medical Director of Pediatric Services Business Development at John R. Oishei Children’s Hospital; President of UBMD Pediatrics (University at Buffalo Pediatric Associates, Inc.); and a Consultant in Pediatrics and Cardio-Oncology for the Roswell Park Comprehensive Cancer Center.


Joseph Carver, Deputy Editor

Joseph Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, the Chief Operating Officer of the Abramson Family Cancer Research Institute of the Abramson Cancer Center of the University of Pennsylvania and the Chief of Staff of the Abramson Cancer Center.


Giorgio Minotti, Deputy Editor

Giorgio Minotti is Professor of Pharmacology, Head of Drug Sciences and Clinical Pharmacology, Chief of Clinical Trial Center, at the University Campus Bio-Medico of Rome. His research interests focus on pharmacokinetics, pharmacodynamics, and clinical correlates of anticancer drugs cardiovascular toxicity.

Annual Journal Metrics

  • 2022 Citation Impact
    3.3 - 2-year Impact Factor
    0.977 - SNIP (Source Normalized Impact per Paper)
    0.790 - SJR (SCImago Journal Rank)

    2023 Speed
    11 days submission to first editorial decision for all manuscripts (Median)
    127 days submission to accept (Median)

    2023 Usage 
    315 Altmetric mentions

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here